A. Donda

Discipline

Histoire, Philosophie et Sociologie des sciences (4) Sciences de l'information et de la communication (1)

Type de document

Articles (16) Recensions (2)

Co-auteur

Date

Source

Mot-clé

T cells (13) Cells (12) Mice (10) Cancer (10) cancer (9) Cancer (9) Melanoma (9) Treatment (8) Immunotherapy (8) Immunotherapy (8) Expression (7) spectacle (5) immunité (5) Control (5) Tumors (5) Immunity (5) Immune response (5) Animals (5) Tumors (5) puits (4) thérapie (4) protéine (4) modèle (4) Development (4) Therapeutics (4) Fusion (4) Example (4) Cell death (4) état (3) infection (3)

Documents écrit par A. Donda (16) | parle de A. Donda (0)

Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity.
N. Dumauthioz et al.
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen.
G.C. Monnot et al. (27 mars 2020)
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma.
P. Lasso et al. (2020)
Lymphocyte-Derived Exosomal MicroRNAs Promote Pancreatic β Cell Death and May Contribute to Type 1 Diabetes Development.
C. Guay et al. (5 févr. 2019)
Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.
N.K. Botelho et al. (2019)
CART cells are prone to Fas- and DR5-mediated cell death.
B.O. Tschumi et al. (13 juil. 2018)
Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth.
P. Lasso et al. (2018)
Correction to: CART cells are prone to Fas- and DR5-mediated cell death.
B.O. Tschumi et al. (2018)
Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses.
L. Zhang et al. (2017)
Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.
A. Gomez-Cadena et al. (2016)
Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.
T. Murray et al. (2016)
Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.
L. Zhang et al. (2016)
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
S. Corgnac et al. (2014)
MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer.
J.C. Dudda et al. (2013)
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
S. Corgnac et al. (2013)
SITC 26th annual meeting - summary.
E. Romano et al. (2012)